TABLE 3.
Least square mean (95% confidence interval) for PCV, plasma total solids, and serum total solids concentrations for the CONT, IV, and RECT treatments at different time points in 5 pigs enrolled in a cross‐over design.
| Analyte | Treatment | T0 | T3 | T6 | T9 | T12 |
|---|---|---|---|---|---|---|
| PCV (%) | CONT | 31 (27, 35) | 32 (28, 36) | 32 (28, 36) | 31 (27, 35) | 32 (28, 37) |
| IV | 34.0 (30, 38) | 28 (24, 32) | 30 (26, 34) | 32 (28, 36) | 31 (27, 35) | |
| RECT | 26 (22, 31) | 31 (27, 35) | 30 (26, 34) | 27 (23, 32) | 29 (26, 34) | |
| Plasma total solids (g/dL) | CONT | 6.0 (5.3, 6.7) | 6.1 (5.4, 6.9) | 6.3 (5.6, 7.0) | 6.0 (5.2, 6.7) | 6.4 (5.7, 7.1) |
| IV | 6.2 (5.5, 6.9) | 4.5 (4.0, 5.4) | 5.4 (4.7, 6.1) | 5.6 (4.9, 6.3) | 5.6 (4.9, 6.3) | |
| RECT | 6.1 (5.4, 6.8) | 6.3 (5.6, 7.0) | 6.3 (5.6, 7.0) | 6.3 (5.6, 7.0) | 6.4 (5.7, 7.1) | |
| Serum total solids (g/dL) | CONT | 6.4 (6.0, 6.7) | – | 6.2 (5.9, 6.6) | – | 6.5 (6.2, 69) |
| IV | 6.2 (5.9, 6.6) | – | 5.7 (5.3, 6.1) | – | 5.9 (5.6, 6.3) | |
| RECT | 6.4 (6.0, 6.7) | – | 6.3 (6.0, 6.7) | – | 6.3 (6.0, 6.7) |
Note: All interaction comparisons between treatment and time were not significant (P > .05). CONT—control treatment. IV—IV treatment. RECT—per rectum infusion treatment. T0—time before treatment. T3, T6, T9, and T12, represent 3, 6, 9, and 12 hours after the beginning of the treatments at sample collection. Serum total solids were not determined at T6 and T9.